Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
Date Market Cap Revenue Earnings PE Sun, 26 Jun 2022 RM3.4b RM2.3b RM226.0m 13.9x Tue, 24 May 2022 RM4.0b RM2.3b RM215.3m 14.4x Thu, 21 Apr 2022 RM4.0b RM2.2b RM204.5m 16.3x Sat, 19 Mar 2022 RM3.7b RM2.2b RM204.5m 16.1x Mon, 14 Feb 2022 RM3.8b RM2.1b RM187.4m 16.3x Wed, 12 Jan 2022 RM3.7b RM2.1b RM187.4m 15.3x Fri, 10 Dec 2021 RM3.7b RM2.1b RM187.4m 15.2x Sun, 07 Nov 2021 RM3.8b RM2.0b RM166.6m 20.4x Tue, 05 Oct 2021 RM3.9b RM2.0b RM166.6m 20.8x Thu, 02 Sep 2021 RM4.2b RM2.0b RM166.5m 21.9x Sat, 31 Jul 2021 RM4.2b RM2.0b RM166.5m 19.5x Tue, 04 May 2021 RM4.3b RM2.0b RM167.4m 18.2x Fri, 05 Feb 2021 RM5.1b RM1.9b RM169.0m 24.1x Mon, 09 Nov 2020 RM5.1b RM2.0b RM169.6m 17.4x Sun, 02 Aug 2020 RM4.4b RM2.0b RM180.8m 16.6x Wed, 06 May 2020 RM2.9b RM2.0b RM175.1m 13x Sat, 08 Feb 2020 RM2.9b RM1.9b RM169.7m 14.1x Fri, 01 Nov 2019 RM2.8b RM1.9b RM173.6m 13.9x Mon, 05 Aug 2019 RM2.7b RM1.9b RM170.8m 14.7x Median PE Ratio
Wed, 03 Jul 2019 Total Market Cap: RM2.7b Total Earnings: RM170.8m Total Revenue: RM1.9b Total Market Cap vs Earnings and Revenue 0% 0% 0% Malaysian Pharma Industry Median PE 3Y Average 16.6x 2020 2021 2022 Current Industry PE Investors are pessimistic on the industry, indicating that they anticipate long-term growth rates will be lower than they have historically. The industry is trading at a PE ratio of 15.1x which is lower than its 3-year average PE of 21.7x. The industry's 3-year average PS ratio 1.9x is higher than the industry's current PS ratio of 1.5x. Past Earnings Growth The earnings for companies in the Pharmaceuticals industry have grown 9.8% per year over the last three years. Revenues for these companies have grown 7.1% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too. Industry Comparison
How does Malaysian Pharma compare with similar industries?
MY Market -1.16% Healthcare 1.25% Pharma -3.23% Pharma -3.23% Industry PEThere is insufficient data on the sub-industries of this industry. Forecasted GrowthThere is insufficient data on the sub-industries of this industry. Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
Simply Wall St ™ Simply Wall Street Pty Ltd 17-21 Bellevue Street, Surry Hills, Sydney
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.